These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

135 related items for PubMed ID: 3027765

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide in turkey cerebral cortex: characterization by [125I]-VIP binding and effects on cyclic AMP synthesis.
    Zawilska JB, Niewiadomski P, Nowak JZ.
    Gen Comp Endocrinol; 2004 Jun; 137(2):187-95. PubMed ID: 15158130
    [Abstract] [Full Text] [Related]

  • 24. Elevation of intracellular cAMP by noradrenaline and vasoactive intestinal peptide in striated ducts isolated from the rabbit mandibular salivary gland.
    Evans RL, Perrott MN, Lau KR, Case RM.
    Arch Oral Biol; 1996 Jul; 41(7):689-94. PubMed ID: 9015570
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Comparative structural requirements of thirty GRF analogs for interaction with GRF- and VIP receptors and coupling to adenylate cyclase in rat adenopituitary, liver and pancreas.
    Robberecht P, Waelbroeck M, Coy D, De Neef P, Camus JC, Christophe J.
    Peptides; 1986 Jul; 7 Suppl 1():53-9. PubMed ID: 3018703
    [Abstract] [Full Text] [Related]

  • 27. Expression of vasoactive intestinal polypeptide receptor mRNA and secretory regulation by vasoactive intestinal polypeptide in rat submandibular and sublingual salivary glands.
    Takai N, Yoshida Y, Shida T, Kondo E, Ueda Y, Kiyama H, Tohyama M.
    Arch Oral Biol; 1997 Mar; 42(3):197-204. PubMed ID: 9188989
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Autoradiographic analysis of the distribution of vasoactive intestinal peptide binding sites in the vertebrate central nervous system: a phylogenetic study.
    Dietl MM, Hof PR, Martin JL, Magistretti PJ, Palacios JM.
    Brain Res; 1990 Jun 18; 520(1-2):14-26. PubMed ID: 2169952
    [Abstract] [Full Text] [Related]

  • 31. Effect of pituitary adenylate cyclase activating polypeptide on rat pancreatic exocrine secretion.
    Mungan Z, Ertan A, Hammer RA, Arimura A.
    Peptides; 1991 Jun 18; 12(3):559-62. PubMed ID: 1717954
    [Abstract] [Full Text] [Related]

  • 32. Receptors for VIP and PACAP in guinea pig cerebral cortex: effects on cyclic AMP synthesis and characterization by 125I-VIP binding.
    Zawilska JB, Dejda A, Niewiadomski P, Gozes I, Nowak JZ.
    J Mol Neurosci; 2005 Jun 18; 25(3):215-24. PubMed ID: 15800375
    [Abstract] [Full Text] [Related]

  • 33. Sequences (103-110) and (116-120) of the rat secretin receptor are implicated in secretin and VIP recognition.
    Robberecht P, Di Paolo E, Moguilevsky N, Bollen A, Waelbroeck M.
    Ann N Y Acad Sci; 2000 Jun 18; 921():362-5. PubMed ID: 11193853
    [No Abstract] [Full Text] [Related]

  • 34. A fragment of vasoactive intestinal peptide, VIP(10-28), is an antagonist of VIP in the colon carcinoma cell line, HT29.
    Turner JT, Jones SB, Bylund DB.
    Peptides; 1986 Jun 18; 7(5):849-54. PubMed ID: 3025826
    [Abstract] [Full Text] [Related]

  • 35. Binding of vasoactive intestinal peptide and its stimulation of adenylate cyclase through two classes of receptors in rat liver membranes. Effects of 12 secretin analogues and 2 secretin fragments.
    Waelbroeck M, Robberecht P, De Neef P, Chatelain P, Christophe J.
    Biochim Biophys Acta; 1981 Nov 18; 678(1):83-90. PubMed ID: 6272875
    [Abstract] [Full Text] [Related]

  • 36. Vasoactive intestinal peptide and intraocular pressure: adenylate cyclase activation and binding sites for vasoactive intestinal peptide in membranes of ocular ciliary processes.
    Mittag TW, Tormay A, Podos SM.
    J Pharmacol Exp Ther; 1987 Apr 18; 241(1):230-5. PubMed ID: 3033201
    [Abstract] [Full Text] [Related]

  • 37. Regulation of the rat proopiomelanocortin gene expression in AtT-20 cells. II: Effects of the pituitary adenylate cyclase-activating polypeptide and vasoactive intestinal polypeptide.
    Aoki Y, Iwasaki Y, Katahira M, Oiso Y, Saito H.
    Endocrinology; 1997 May 18; 138(5):1930-4. PubMed ID: 9112389
    [Abstract] [Full Text] [Related]

  • 38. Pharmacology, molecular identification and functional characteristics of vasoactive intestinal peptide receptors in human breast cancer cells.
    Gespach C, Bawab W, de Cremoux P, Calvo F.
    Cancer Res; 1988 Sep 15; 48(18):5079-83. PubMed ID: 2842044
    [Abstract] [Full Text] [Related]

  • 39. HT 29, a model cell line: stimulation by the vasoactive intestinal peptide (VIP); VIP receptor structure and metabolism.
    Marchis-Mouren G, Martin JM, Luis J, el Battari A, Muller JM, Marvaldi J, Pichon J.
    Biochimie; 1988 May 15; 70(5):663-71. PubMed ID: 2844304
    [Abstract] [Full Text] [Related]

  • 40. Vasoactive intestinal peptide (VIP) stimulates in vitro growth of VIP-1 receptor-bearing human pancreatic adenocarcinoma-derived cells.
    Jiang S, Kopras E, McMichael M, Bell RH, Ulrich CD.
    Cancer Res; 1997 Apr 15; 57(8):1475-80. PubMed ID: 9108448
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.